MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
RNTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Rein Therapeutics (RNTX) Ownership - Who owns Rein Therapeutics?

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
77.8M
P/E Ratio
N/A
Total Cash
4.05M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
2.07
Dividend Yield
N/A
Total Cash/Share
0.05
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
RNTX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for RNTX
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details